University of Arizona- Sarver Heart Center
Tucson, Arizona 85724-5046
5 studies enrolling now · 22 studies all time
What they study most
Acute Kidney Injury, Acute Myocardial Infarction, Amyloidosis, Immunoglobulin Light-chain, Atherosclerosis, Atrial Fibrillation, Cardiac Fibrosis, Cardiovascular Diseases, Chronic Heart Failure, Cognitive Impairment, Coronary Artery Bypass Surgery, Coronary Restenosis, Diastolic Dysfunction
Studies at this site
- Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy — Recruiting now
- AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF — Recruiting now
- Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II — Recruiting now
- CardioFocus HeartLight Post-Approval Study — Recruiting now
- Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
- DCM Precision Medicine Study — Running, not enrolling
- Angiotensin (1-7) Treatment to Improve Cognitive Functioning in Heart Failure Patients — Paused
- Evaluation of the Safety and Efficacy of Ang-(1-7) to Enhance Cognitive Function in Participants Undergoing CABG — Stopped early
- REmodeling the Left Ventricle With Atrial Modulated Pacing — Completed
- A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation — Stopped early
- Cardiac Amyloidosis Registry Study — Status unconfirmed
- Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH — Stopped early
- Strategic Management to Optimize Response To Cardiac Resynchronization Therapy — Completed
- Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF) — Completed
- INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure — Completed
- Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C — Completed
- Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure — Completed
- Novel INXN-4001 Triple Effector Plasmid in Heart Failure — Completed
- A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery — Completed
- Effects of Pycnogenol on Cardiac Fibrosis and Diastolic Dysfunction in Aged Hypertensive Subjects — Stopped early
- Study of DITPA in Patients With Congestive Heart Failure — Stopped early
- A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels. — Completed